UniProt ID | HOIL1_RAT | |
---|---|---|
UniProt AC | Q62921 | |
Protein Name | RanBP-type and C3HC4-type zinc finger-containing protein 1 | |
Gene Name | Rbck1 | |
Organism | Rattus norvegicus (Rat). | |
Sequence Length | 508 | |
Subcellular Localization | ||
Protein Description | Component of the LUBAC complex which conjugates linear ('Met-1'-linked) polyubiquitin chains to substrates and plays a key role in NF-kappa-B activation and regulation of inflammation. LUBAC conjugates linear polyubiquitin to IKBKG and RIPK1 and is involved in activation of the canonical NF-kappa-B and the JNK signaling pathways. Linear ubiquitination mediated by the LUBAC complex interferes with TNF-induced cell death and thereby prevents inflammation. LUBAC is proposed to be recruited to the TNF-R1 signaling complex (TNF-RSC) following polyubiquitination of TNF-RSC components by BIRC2 and/or BIRC3 and to conjugate linear polyubiquitin to IKBKG and possibly other components contributing to the stability of the complex. Together with FAM105B/otulin, the LUBAC complex regulates the canonical Wnt signaling during angiogenesis. Binds polyubiquitin of different linkage types (By similarity). E3 ubiquitin-protein ligase, which accepts ubiquitin from specific E2 ubiquitin-conjugating enzymes, such as UBE2L3/UBCM4, and then transfers it to substrates. Functions as an E3 ligase for oxidized IREB2 and both heme and oxygen are necessary for IREB2 ubiquitination. Promotes ubiquitination of TAB2 and IRF3 and their degradation by the proteasome.. | |
Protein Sequence | MDEKTKKAEEMALSLARAVTGGDEQAAIKYATWLAEQKVPLRVQVKPEVSPTQDIRLCVSVEDAYMHTVTIWLTVRPDMTVASLKDMVFLDYGFPPSLQQWVVGQRLARDQETLHSHGIRRNGDSAYLYLLSARNTSLNPQELQRQRQLRMLEDLGFKDLTLQPRGPLEPVLPKPRTHQETGQPDAAPESPPVGWQCPGCTFINKPTRPGCEMCCRARPEAYQIPASYQPDEEERARLAGEEEALRQYEQRKQQQQEGNYLQHVQLEQRSLVLNTEPAECPVCYSVLAPGEAVVLRECLHTFCRECLQGTIRNSQEAEVSCPFIDNTYSCPGKLLEREIRALLSPEDYQRFLDLGVSIAENRSTLSYHCKTPDCRGWCFFEDDVNEFTCPVCTRVNCLLCKAIHERMNCREYQDDLAHRARNDVAAQQTTEMLRVMLQQGEAMYCPQCRIVVQKKDGCDWIRCTVCHTEICWVTKGPRWGPGGPGDTSGGCRCRVNGIPCHPSCQNCH | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MDEKTKKA -------CCHHHHHH | 15.76 | - | |
50 | Phosphorylation | VQVKPEVSPTQDIRL EEECCCCCCCCCEEE | 22.14 | 30181290 | |
52 | Phosphorylation | VKPEVSPTQDIRLCV ECCCCCCCCCEEEEE | 31.22 | 30181290 | |
137 | Phosphorylation | LLSARNTSLNPQELQ HHHHCCCCCCHHHHH | 29.69 | 18303026 | |
161 | Phosphorylation | DLGFKDLTLQPRGPL HCCCCCCCCCCCCCC | 33.22 | 18303026 | |
207 | Phosphorylation | CTFINKPTRPGCEMC CEEECCCCCCCCHHC | 51.62 | 18303026 | |
270 | Phosphorylation | HVQLEQRSLVLNTEP HHHHHHCEEEECCCC | 23.64 | 18303026 | |
275 | Phosphorylation | QRSLVLNTEPAECPV HCEEEECCCCCCCCC | 38.90 | 18303026 | |
285 | Phosphorylation | AECPVCYSVLAPGEA CCCCCEEEEECCCCC | 12.91 | 18303026 | |
328 | Phosphorylation | CPFIDNTYSCPGKLL CCCCCCCCCCCCHHH | 17.96 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
137 | S | Phosphorylation | Kinase | PRKCB | P05771 | GPS |
161 | T | Phosphorylation | Kinase | PRKCB | P05771 | GPS |
207 | T | Phosphorylation | Kinase | PRKCB | P05771 | GPS |
270 | S | Phosphorylation | Kinase | PRKCB | P05771 | GPS |
275 | T | Phosphorylation | Kinase | PRKCB | P05771 | GPS |
285 | S | Phosphorylation | Kinase | PRKCB | P05771 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of HOIL1_RAT !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of HOIL1_RAT !! |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...